Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality.

A better understanding of the composition of optimal treatment regimens for multidrug-resistant tuberculosis (MDR-TB) is essential for expanding universal access to effective treatment and for developing new therapies for MDR-TB. Analysis of observational data may inform the definition of an optimiz...

Full description

Bibliographic Details
Main Authors: Carole D Mitnick, Molly F Franke, Michael L Rich, Felix A Alcantara Viru, Sasha C Appleton, Sidney S Atwood, Jaime N Bayona, Cesar A Bonilla, Katiuska Chalco, Hamish S F Fraser, Jennifer J Furin, Dalia Guerra, Rocio M Hurtado, Keith Joseph, Karim Llaro, Lorena Mestanza, Joia S Mukherjee, Maribel Muñoz, Eda Palacios, Epifanio Sanchez, Kwonjune J Seung, Sonya S Shin, Alexander Sloutsky, Arielle W Tolman, Mercedes C Becerra
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3596279?pdf=render